Flu Vaccination in Pharmacies Secured Long-Term
Starting October 15, 2025, pharmacies will permanently offer flu vaccinations. Pharma Germany sees this as a key step for prevention and public health.
B2B Marketing Budgets 2025 Under Pressure
The new bvik study reveals: B2B marketing budgets are declining in 2025 for the first time in five years. Still, companies are focusing on lead generation, digital infrastructure, and marketing automation.
Pharmaceutical Industry Remains Top Employer in Germany
Despite economic uncertainties, the pharmaceutical sector remains one of Germany’s most attractive employers. A recent survey shows: 76.5% rate the industry as attractive.
What truly makes the difference here?
AstraZeneca Germany has launched a new employer branding campaign where employees openly share how their work makes a difference for them and for society.
ABDA at expopharm 2025: Strong Presence in Düsseldorf
expopharm 2025 in Düsseldorf features numerous events with ABDA participation – from pharmaceutical services to key questions on the future of healthcare.
Lilly builds multi-billion-dollar site in Alzey
Eli Lilly is investing $2.5 billion in a new production site in Alzey, Germany. The facility will create up to 1,000 new jobs in the pharmaceutical industry.
The New Power of Routines
Personal care is more than cosmetics – it’s becoming a global foundation for health, well-being, and prevention. A new study reveals how routines are changing lives.
100 days of ePA: Awareness stagnates, usage remains low
100 days after its launch, Germany’s electronic health record (ePA) is only used by a small number of insured persons. Technical barriers and lack of information slow down progress.
Norgine completes acquisition of Theravia
Norgine has successfully completed the acquisition of Theravia, strengthening its rare disease portfolio and market presence across Europe and ANZ.
DKV Report 2025: Germany on the Move Too Little
The DKV Report 2025 reveals alarming trends in Germany’s health behavior: only 2% of the population meets all the benchmarks for a healthy lifestyle. Lack of exercise, chronic stress and excessive sitting are major concerns.
New Look, Trusted Quality: sebamed Relaunch 2025
Starting in August 2025, sebamed presents a modern packaging redesign that combines transparency, medical expertise, and sustainability – with the same trusted quality.
Alarming Stress Levels Among Primary School Children
A new study shows that even primary school children are under significant stress. Academic pressure, bullying, and media use are major contributors.
Gen Z Trusts AI for Health Decisions
The new Better Health Report 2025 from Simon-Kucher and AESGP reveals a digital shift in prevention: AI is becoming a trusted tool in self-care – especially for Gen Z.
BPI launches Radiopharmaceuticals Working Group
BPI has launched the Radiopharmaceuticals Working Group to foster exchange on regulatory, scientific, and healthcare policy challenges in this innovative drug class.
Publicis Health Acquires p-value Group
Publicis Health strengthens its medical communications capabilities across the full product lifecycle by acquiring p-value Group.
Strong Commitment to Cancer Care: Cancer Aid Releases Report
In 2024, German Cancer Aid launched 164 new cancer-fighting projects funded by €181 million in donations – including research, new care models, and patient support.
Pharmacy Day 2026: Save the Date!
On March 25, 2026, the Thuringian Chamber of Pharmacists invites students to the Pharmacy Day in Jena. Under the motto “Your Prescription for Life”, participants will gain exciting insights into the pharmacy profession.
Takeda Relocates German HQ to Berlin
Takeda is relocating the headquarters of Takeda GmbH from Konstanz to Berlin, focusing future operations on Berlin, Oranienburg, and Singen.
Campaign Germany: Submit now for Agency of the Year 2025!
The Campaign Germany Agency of the Year Awards honor the best agencies and standout individuals – submissions open until July 25, 2025!
Nordic Capital and Permira plan takeover of Bavarian Nordic
A consortium led by Nordic Capital and Permira plans to acquire Danish vaccine company Bavarian Nordic in a deal worth around DKK 19 billion.